SMAD3 and renal fibrosis: The activation of SIRT1 has been shown to inhibit TGF-β/Smad3 signaling, thereby reducing Smad3 acetylation and improving renal fibrosis in 5/6 nephrectomized rats (Huang et al., 2014).